— NDA accepted and granted Priority Review following its Breakthrough Therapy designation granted in January 2022 — — NDA is...
- ATTRibute-CM demonstrated a significant treatment effect of acoramidis on the primary endpoint (a hierarchical analysis inclusive of all-cause mortality...
BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 10 January 2024, 23:00 CET Disclosure of transparency...
BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 10 January 2024, 23:00 CET Disclosure of transparency...
SAN DIEGO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2024,...
AUDUBON, Pa., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced...
Leading distributor of surgical robotics to elevate MMI’s presence in ItalyJACKSONVILLE, Fla.--(BUSINESS WIRE)--MMI, (Medical Microinstruments, Inc.), a robotics company dedicated...
CGI (TSX:GIB.A) (NYSE:GIB), one of the largest IT and business consulting companies in the world, and Tribun Health, a rising...